BR0103033A - Partìculas farmacêuticas de sabor mascarado - Google Patents

Partìculas farmacêuticas de sabor mascarado

Info

Publication number
BR0103033A
BR0103033A BR0103033-7A BR0103033A BR0103033A BR 0103033 A BR0103033 A BR 0103033A BR 0103033 A BR0103033 A BR 0103033A BR 0103033 A BR0103033 A BR 0103033A
Authority
BR
Brazil
Prior art keywords
masked
active ingredient
particles
core
flavor
Prior art date
Application number
BR0103033-7A
Other languages
English (en)
Inventor
Daniel Mcteigue
Narendra Parikh
David W Wynn
Ravivaj S Pillai
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BR0103033A publication Critical patent/BR0103033A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "PARTìCULAS FARMACêUTICAS DE SABOR MASCARADO". São reveladas partículas de sabor mascarado e comprimidos mastigáveis feitos a partir delas. As partículas de sabor mascarado consistem em um núcleo contendo um ingrediente ativo e um revestimento polimérico cobrindo o referido núcleo, consistindo o referido núcleo de uma mistura em a) um polímero entérico e b) um polímero formador de película insolúvel, sendo a superfície da referida partícula livre de ingrediente ativo. Os comprimidos mastigáveis proporcionam liberação imediata do ingrediente ativo.
BR0103033-7A 2000-06-30 2001-07-02 Partìculas farmacêuticas de sabor mascarado BR0103033A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21550500P 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
BR0103033A true BR0103033A (pt) 2002-03-05

Family

ID=22803235

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103033-7A BR0103033A (pt) 2000-06-30 2001-07-02 Partìculas farmacêuticas de sabor mascarado

Country Status (17)

Country Link
US (2) US7223421B2 (pt)
EP (1) EP1166777B1 (pt)
JP (1) JP2002087952A (pt)
KR (1) KR20020002321A (pt)
CN (1) CN1356102A (pt)
AR (1) AR029546A1 (pt)
AT (1) ATE404180T1 (pt)
AU (1) AU784613B2 (pt)
BR (1) BR0103033A (pt)
CA (1) CA2351814C (pt)
CO (1) CO5271674A1 (pt)
DE (1) DE60135273D1 (pt)
ES (1) ES2311500T3 (pt)
MX (1) MXPA01006803A (pt)
NZ (1) NZ512683A (pt)
SA (1) SA01220402B1 (pt)
ZA (1) ZA200105407B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1685839T1 (sl) 1997-12-22 2013-08-30 Euro-Celtique S.A. Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
US8268333B2 (en) 2001-04-24 2012-09-18 Lintec Corporation Orally administered agent and an orally administered agent/supporting substrate complex
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
IL164106A0 (en) * 2002-04-04 2005-12-18 Pfizer Prod Inc Palatable chewable tablet
KR20040098050A (ko) 2002-04-05 2004-11-18 유로-셀띠끄 소시에떼 아노님 옥시코돈 및 날록손을 포함하는 약제학적 제제
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040258752A1 (en) * 2003-01-31 2004-12-23 Paruthi Manoj Kumar Taste masking pharmaceutical composition and process for its preparation
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20040213838A1 (en) * 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
JPWO2005000358A1 (ja) * 2003-06-27 2006-08-03 湧永製薬株式会社 安定液剤
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8062659B2 (en) * 2004-02-20 2011-11-22 Novartis Ag Dietary fiber composition
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
JP5704789B2 (ja) * 2005-01-28 2015-04-22 ユーロ−セルティーク エス．エイ． 耐アルコール性剤形
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1813276A1 (en) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
WO2007123153A1 (ja) * 2006-04-19 2007-11-01 Ono Pharmaceutical Co., Ltd. 経口投与用カプセル
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20080031927A1 (en) * 2006-07-11 2008-02-07 Catani Steven J Solid oral dosage vitamin and mineral compositions
MX2009004439A (es) * 2006-10-25 2009-05-11 Mcneil Ppc Inc Composicion de ibuprofeno.
FR2930147B1 (fr) * 2008-04-18 2013-02-08 Flamel Tech Sa Forme orale solide dotee d'un double profil de liberation
CA2730211C (en) * 2008-07-07 2016-11-08 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
EP2405915B1 (en) 2009-03-10 2018-10-24 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US20100239681A1 (en) * 2009-03-20 2010-09-23 Biokey, Inc. Controlled Release Particulates Containing Water-Insoluble Drug
CN102858373B (zh) * 2010-03-31 2014-11-26 持田制药株式会社 易服用性固体制剂
CN103813807B (zh) 2011-09-30 2017-02-08 持田制药株式会社 易服用性固体制剂
FR2999426B1 (fr) * 2012-12-13 2015-01-02 Flamel Tech Sa Forme orale multiparticulaire a liberation immediate d'au moins un compose actif, comprenant des particules enrobees resistantes au broyage.
JP5836980B2 (ja) 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN112674348A (zh) * 2020-12-23 2021-04-20 石药集团中诺药业（泰州）有限公司 一种b族维生素含片和咀嚼片制备方法
WO2024020361A2 (en) * 2022-07-19 2024-01-25 Michael Ogburn Inhalable serotonin receptor agonist formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103718A (pt) 1972-04-14 1973-12-26
US4160827A (en) * 1978-02-06 1979-07-10 The Upjohn Company Metronidazole phosphate and salts
JPS5535031A (en) 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
US4749575A (en) 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4971791A (en) 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4916161A (en) 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
CA2063141C (en) * 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
FI922107A0 (fi) 1991-05-10 1992-05-08 Faulding F H & Co Ltd Mikrokapselkomposition och foerfarande.
US5837277A (en) 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
PT621032E (pt) 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
GB9317897D0 (en) * 1993-08-27 1993-10-13 Plessey Telecomm Telecommunications switching element
JPH07223970A (ja) 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
US5536507A (en) 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
JP3355593B2 (ja) * 1994-08-19 2002-12-09 信越化学工業株式会社 固形腸溶製剤の製造方法
EP1007012A4 (en) 1996-10-01 2006-01-18 Cima Labs Inc TASTE-MASKED MICRO-CAPSULE COMPOSITION AND MANUFACTURING PROCESS
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations

Also Published As

Publication number Publication date
CA2351814C (en) 2009-11-17
NZ512683A (en) 2003-02-28
CO5271674A1 (es) 2003-04-30
EP1166777B1 (en) 2008-08-13
AU5415801A (en) 2002-01-03
CN1356102A (zh) 2002-07-03
JP2002087952A (ja) 2002-03-27
AR029546A1 (es) 2003-07-02
DE60135273D1 (de) 2008-09-25
US7223421B2 (en) 2007-05-29
SA01220402B1 (ar) 2007-02-07
ATE404180T1 (de) 2008-08-15
EP1166777A1 (en) 2002-01-02
AU784613B2 (en) 2006-05-11
ZA200105407B (en) 2003-01-02
US20070196489A1 (en) 2007-08-23
MXPA01006803A (es) 2003-08-20
US20020031552A1 (en) 2002-03-14
ES2311500T3 (es) 2009-02-16
CA2351814A1 (en) 2001-12-30
KR20020002321A (ko) 2002-01-09

Similar Documents

Publication Publication Date Title
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
UA63993C2 (uk) Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
BR0106912A (pt) Partìculas contendo ingrediente ativo
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
WO2002072034A3 (en) Chronotherapeutic dosage forms
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
ATE244002T1 (de) Pharmazeutische formulierung mit omeprazol
ATE376414T1 (de) Pellet formulierung mit gesteuerter freisetzung
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
DE60321386D1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
AU3345197A (en) Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
WO2005027843A3 (en) Chronotherapeutic dosage forms
MY127350A (en) Flash-melt oral dose formulations
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AP1595A (en) Pharmaceutical formulation having a masked taste and method for the production thereof.
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
WO2003018535A3 (en) Novel aminobenzoephenones
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ) , O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]